Amyloid transformations of phenol soluble modulin α1 in Staphylococcus aureus and their modulation deploying a

Nikita Admane1, Ram Kothandan2, Sumit Biswas3

  • 1ViStA Laboratory, Department of Biological Sciences, BITS, Pilani - KK Birla Goa Campus, Goa, 403726, India.

Scientific Reports
|August 10, 2024
PubMed

Insights

Isobavachalcone (IBC) inhibits phenol soluble modulin (PSM) α1 amyloid fibrillation, a key factor in antibiotic-resistant staphylococcal biofilms. This discovery offers a novel strategy for developing therapeutics against resilient bacterial infections.

Area of Science:

  • Microbiology
  • Biochemistry
  • Drug Discovery

Background:

  • Phenol soluble modulins (PSMs) are amphipathic peptides crucial for staphylococcal pathogenesis.
  • PSMs promote amyloid-like fibril formation, stabilizing biofilms and conferring antibiotic resistance.

Purpose of the Study:

  • To investigate the potential of Isobavachalcone (IBC), a prenylated chalcone, in inhibiting PSM α1 amyloid fibrillation.
  • To elucidate the mechanism by which IBC modulates PSM α1 fibrillation.

Main Methods:

  • Biophysical assays including Thioflavin T (ThT) kinetics and Transmission Electron Microscopy (TEM).
  • Far-UV Circular Dichroism (CD) spectroscopy to assess secondary structure changes.
  • Molecular Dynamics (MD) simulations to model IBC's interaction with PSM aggregates.

Main Results:

  • IBC significantly reduced PSM α1 amyloid formation by up to 94% at sub-stoichiometric concentrations.
  • TEM revealed a marked decrease in mature fibril formation in the presence of IBC.
  • CD and MD simulations confirmed IBC's inhibition of β-sheet transitions and disruption of hydrogen bonding in PSM aggregates.

Conclusions:

  • IBC effectively abrogates PSM α1 amyloid fibrillation through interaction with monomers or early aggregates.
  • This study proposes a novel structural motif for developing non-toxic therapeutic agents targeting functional amyloids in antibiotic-resistant biofilms.